Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted 13 December, 2012 and appeared in  CardiovascularIssue 656

Blood Sugar Drops, Heart Problems Rise

Hypoglycemia in type 2 diabetes may increase risk of cardiovascular events and death....
Advertisement

High blood sugar isn't the only thing that's dangerous for patients with diabetes. Low blood sugar can also do damage.

Type 2 diabetes patients with hypoglycemia may have a higher risk of heart problems, hospitalization and death, according to a recent study.

Results showed that diabetes patients had these increased risks whether they had mild or severe hypoglycemia. That is, any amount of low blood sugar was associated with an increased risk of complications.

Past research has shown that low blood sugar can lead to serious health problems in patients with type 2 diabetes. However, the outcomes of diabetes patients with mildly low blood sugar is still unclear. To address this issue, Pai-Feng Hsu, MD, of Taipei Veterans General Hospital in Taiwan, and colleagues studied the outcomes of diabetes patients who had experienced periods of low blood sugar.

Compared to those without low blood sugar, patients who experienced either mild or severe low blood sugar had higher rates of complications, including:

  • high blood pressure
  • kidney disease
  • cancer
  • stroke
  • heart disease

The researchers also found that patients with either mild or severe low blood sugar had a higher risk of:

  • heart disease, with a hazard ratio of 2.09
  • hospitalization from any cause, with a hazard ratio of 2.51
  • death, with a hazard ratio of 2.48

A hazard ratio explains how much an event happens in one group versus another. A hazard ratio of more than 1.0 means the event happens more often in the first group.

In this case, the events were heart disease, hospitalization and death. All of the hazard ratios were more than 2.0, indicating that those with low blood sugar had significantly higher risks of these events than those without low blood sugar.

According to the authors, these findings suggest that diabetes patients with episodes of low blood sugar may need more attention from their doctors.

The study included 77,611 patients who experienced 1,844 episodes of low blood sugar. Of these episodes, 500 were severe and 1,344 were mild.

Diabetes Care, Dec. 5, 2012 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 13 December, 2012 and appeared in  CardiovascularIssue 656

Past five issues: Diabetes Clinical Mastery Series Issue 203 | Issue 743 | Diabetes Clinical Mastery Series Issue 202 | SGLT-2 Inhibitors Special Edition August 2014 | GLP-1 Special Editions August 2014 |

2014 Most Popular Articles:

Low-carb Diet Recommended for Type 1 and 2 Diabetes Patients
Posted August 01, 2014
New Combination of Diabetes Drugs Have Synergistic Effect
Posted August 08, 2014
New Encapsulated Beta-Cell Replacement Therapy for Type 1 Diabetes
Posted August 08, 2014
FDA Approves J&J's Invokamet Combo (SGLT-2 + Metformin)
Posted August 15, 2014
During Prolonged Low-Intensity Exercise, Caffeine Alters Blood Glucose
Posted August 15, 2014
HbA1c Increases with Age
Posted August 01, 2014
SGLT2 Inhibitor Empagliflozin Wins FDA OK
Posted August 08, 2014
Diabetic Neuropathy Improved with Vegan Diet
Posted August 22, 2014
New Way to Regenerate Beta Cells in Type 1 Diabetes Patients
Posted August 08, 2014
Statin Adherence Linked to New Onset Diabetes Risk
Posted July 25, 2014


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Bernstein | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you recommend SGLT-2 drugs for type 1 diabetes?
CME/CE of the Week
Kathleen Berra, MSN, ANP

Category: CDE
Credits:
 .75
Search Articles On Diabetes In Control